Reid Merryman, Md
Clinical trials sponsored by Reid Merryman, Md, explained in plain language.
-
New drug duo aims to train immune system to fight blood cancer
Disease control Recruiting nowThis study is testing a new combination of two immune-based drugs, epcoritamab and rituximab, for people with follicular lymphoma who have not yet received any treatment. The goal is to see how well and how safely this drug pair works to control the cancer. About 100 participants…
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated Apr 02, 2026 03:42 UTC
-
New drug cocktail aims to wipe out stubborn lymphoma
Disease control Recruiting nowThis study is testing whether a combination of three drugs—epcoritamab, zanubrutinib, and rituximab—is safe and effective for people whose follicular or marginal zone lymphoma has come back or hasn't responded to prior treatments. About 45 participants will receive the treatment …
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC